A gene named DEK has been identified as potentially responsible for the degeneration of neurons vulnerable to Alzheimer’s Disease (AD), particularly in the entorhinal cortex, a critical area for memory formation. By manipulating levels of DEK in experimental models and neurons in vitro, researchers observed increased tau accumulation and neuron degeneration, suggesting a new therapeutic target.